NEW YORK – University Hospital Tübingen in Germany is embarking on a new project, called Ge-Med, that will replace diagnostic exome sequencing with whole-genome sequencing across a variety of genetic conditions, including familial cancer syndromes and rare genetic disorders. The program is also among the first to explore polygenic risk scores (PRS) in a routine clinical setting.
German Medical Center to Report Polygenic Risk Scores as Part of Clinical Whole-Genome Testing
Premium
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.